| Latvia | | |
Time spent for sleeping (men and women, minutes per day per person) | 512.3 (2003) [15/33countries] | | | Time spent for sleeping (men, minutes per day per person) | 510.1 (2003) [13/33countries] | | | Time spent for sleeping (women, minutes per day per person) | 515.5 (2003) [12/33countries] | | |
|
| Latvia | | |
Time spent for eating and drinking (men and women, minutes per day per person) | 88.9 (2003) [18/33countries] | | | Time spent for eating and drinking (men, minutes per day per person) | 93.0 (2003) [15/33countries] | | | Time spent for eating and drinking (women, minutes per day per person) | 84.9 (2003) [20/33countries] | | |
|
| Latvia | | |
Age-standardized prevalence of tobacco use among persons 15 years and olders (%) | 37.0% (2020) [10/164countries] | | |
|
| Latvia | | |
Tuberculosis incidence (per 100,000 population) | 16.0 (2021) [131/198countries] | | | Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%) | 0.3 (2020) [84/194countries] | | | Reported number of people requiring interventions against NTDs | 6 (2021) [35/83countries] | | | Probability of dying from any of CVD, cancer, diabetes, CRD between age 30-70 (%) | 21.6 (2019) [75/183countries] | | | % of those who think that antibiotics can kill bacteria but not viruses | 68.0% (2000) [25/25countries] | | | % of those who think that all man-made chemicals can cause cancer if they eat enough of them | 71.2% (2000) [12/25countries] | | |
|
| Latvia | | |
Incidents of all cancers (age-standardized rate, per 100,000 population) | 301.5 (2020) [17/185countries] | | | Incidents of cancer at bladder (age-standardized rate, per 100,000 population) | 12.3 (2020) [18/184countries] | | | Incidents of cancer at brain, central nervous system (age-standardized rate, per 100,000 population) | 7.5 (2020) [4/181countries] | | | Incidents of cancer at breast (age-standardized rate, per 100,000 population) | 63.6 (2020) [50/185countries] | | | Incidents of cancer at cervix uteri (age-standardized rate, per 100,000 population) | 18.4 (2020) [64/185countries] | | | Incidents of cancer at colorectum (age-standardized rate, per 100,000 population) | 92.5 (2020) [7/185countries] | | | Incidents of cancer at corpus uteri (age-standardized rate, per 100,000 population) | 17.6 (2020) [23/183countries] | | | Incidents of cancer at gallbladder (age-standardized rate, per 100,000 population) | 0.4 (2020) [125/177countries] | | | Incidents of cancer at kidney (age-standardized rate, per 100,000 population) | 13.5 (2020) [5/182countries] | | | Incidents of cancer at larynx (age-standardized rate, per 100,000 population) | 3.4 (2020) [20/184countries] | | | Incidents of cancer at leukaemia (age-standardized rate, per 100,000 population) | 7.8 (2020) [24/185countries] | | | Incidents of cancer at lip and oral cavity (age-standardized rate, per 100,000 population) | 6.0 (2020) [10/183countries] | | | Incidents of cancer at liver (age-standardized rate, per 100,000 population) | 3.2 (2020) [159/185countries] | | | Incidents of cancer at lung (age-standardized rate, per 100,000 population) | 26.4 (2020) [42/185countries] | | | Incidents of cancer at skin (age-standardized rate, per 100,000 population) | 11.7 (2020) [50/183countries] | | | Incidents of cancer at multiple myeloma (age-standardized rate, per 100,000 population) | 2.6 (2020) [47/178countries] | | | Incidents of cancer at nasopharynx (age-standardized rate, per 100,000 population) | 0.3 (2020) [117/172countries] | | | Incidents of cancer at lymphoma (age-standardized rate, per 100,000 population) | 9.8 (2020) [39/184countries] | | | Incidents of cancer at oesophagus (age-standardized rate, per 100,000 population) | 3.7 (2020) [48/183countries] | | | Incidents of cancer at oropharynx (age-standardized rate, per 100,000 population) | 1.5 (2020) [41/173countries] | | | Incidents of cancer at ovary (age-standardized rate, per 100,000 population) | 15.1 (2020) [3/185countries] | | | Incidents of cancer at pancreas (age-standardized rate, per 100,000 population) | 8.8 (2020) [10/184countries] | | | Incidents of cancer at prostate (age-standardized rate, per 100,000 population) | 87.6 (2020) [18/185countries] | | | Incidents of cancer at stomach (age-standardized rate, per 100,000 population) | 12.0 (2020) [33/184countries] | | | Incidents of cancer at testis (age-standardized rate, per 100,000 population) | 3.1 (2020) [54/174countries] | | | Incidents of cancer at thyroid (age-standardized rate, per 100,000 population) | 10.2 (2020) [21/184countries] | | |
|
| Latvia | | |
Suicide, age-standardized (per 100 000 population) | 16.06 (2019) [24/183countries] | | | Suicide - male, age-standardized (per 100 000 population) | 29.01 (2019) [22/183countries] | | | Suicide - female, age-standardized (per 100 000 population) | 4.56 (2019) [80/183countries] | | | Suicide - 15-24 years (per 100,000 population) | 10.01 (2019) [44/183countries] | | | Suicide - 15-24 years, male (per 100,000 population) | 17.84 (2019) [26/183countries] | | | Suicide - 15-24 years, female (per 100,000 population) | 1.74 (2019) [130/183countries] | | | Suicide - 25-34 years (per 100,000 population) | 22.22 (2019) [18/183countries] | | | Suicide - 25-34 years, male (per 100,000 population) | 36.57 (2019) [16/183countries] | | | Suicide - 25-34 years, female (per 100,000 population) | 7.10 (2019) [28/183countries] | | | Suicide - 35-44 years (per 100,000 population) | 24.46 (2019) [20/183countries] | | | Suicide - 35-44 years, male (per 100,000 population) | 43.01 (2019) [17/183countries] | | | Suicide - 35-44 years, female (per 100,000 population) | 5.94 (2019) [56/183countries] | | | Suicide - 45-54 years (per 100,000 population) | 28.85 (2019) [17/183countries] | | | Suicide - 45-54 years, male (per 100,000 population) | 53.52 (2019) [14/183countries] | | | Suicide - 45-54 years, female (per 100,000 population) | 6.15 (2019) [82/183countries] | | | Suicide - 55-64 years (per 100,000 population) | 26.71 (2019) [36/183countries] | | | Suicide - 55-64 years, male (per 100,000 population) | 51.20 (2019) [27/183countries] | | | Suicide - 55-64 years, female (per 100,000 population) | 7.03 (2019) [87/183countries] | | | Suicide - 65-74 years (per 100,000 population) | 21.48 (2019) [67/183countries] | | | Suicide - 65-74 years, male (per 100,000 population) | 42.95 (2019) [54/183countries] | | | Suicide - 65-74 years, female (per 100,000 population) | 8.35 (2019) [87/183countries] | | | Suicide - 75-84 years (per 100,000 population) | 26.93 (2019) [70/183countries] | | | Suicide - 75-84 years, male (per 100,000 population) | 57.96 (2019) [58/183countries] | | | Suicide - 75-84 years, female (per 100,000 population) | 13.16 (2019) [74/183countries] | | | Suicide - 85 years and over (per 100,000 population) | 25.59 (2019) [100/183countries] | | |
|
| Latvia | | |
Density of medical doctors (per 10,000 population) | 33.5 (2013?2021) [45/192countries] | | | Density of nursing and midwifery personnel (per 10,000 population) | 44.0 (2013?2021) [83/195countries] | | | Density of dentists (per 10,000 population) | 7.2 (2013?2021) [40/171countries] | | | Density of pharmacists (per 10,000 population) | 8.8 (2013?2021) [33/175countries] | | | Hospital beds (number per 1,000 population) | 5.5 (2018) [18/110countries] | | | Inpatient care average length of stay days | 8.1 (2021) [11/32countries] | | | Health expenditure (% of GDP) | 8.8% (2022) [26/50countries] | | | Population with household expenditures on health > 10% of total household expenditure or income (%) | 21.4 (2013?2021) [8/132countries] | | | % of those who agree that the government is responsible for providing health care for the sick | 98.1% (2016) [11/35countries] | | | % of those who would like to see more government spending in health | 90.7% (2016) [8/35countries] | | | % of those who think that the government is successful in health care | 10.2% (2016) [23/23countries] | | | % of those who think that hospitals should mainly be run by private organizations or companies | 14.6% (1996) [16/23countries] | | |
|
|